Observational studyJMIR infodemiology2025

Harnessing Facebook to Investigate Real-World Mentions of Adverse Events of Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications: Observational Study of Facebook Posts From 2022 to 2024.

Amrutha S Alibilli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.